FDA Stresses Dangers Of Transplant Drugs
The U.S. Food and Drug Administration initially released warnings and revised the labels for Roche's CellCept and Novartis' Myfortin drugs in November amid reports of miscarriages and ear and mouth deformities in infants after their mothers took the drugs to prevent organ rejection.
The drugs are used to suppress the body's immune system to avoid organ rejection in transplant patients....
Already a subscriber? Click here to login